Home › Funds › Marshall Wace › MXCT
Marshall Wace position in MXCT
MAXCYTE INC · Health Care
Latest position (Q2 2026)1.01M sh
Reported value held$1.25M
Portfolio Weight0.00%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 986.44K | $10.05M | New |
| Q2 2022 | 257.07K | $1.22M | New |
| Q2 2024 | 499.67K | $1.96M | New |
| Q3 2024 | 222.59K | $865.89K | Reduce |
| Q4 2024 | 252.33K | $1.05M | Add |
| Q2 2025 | 129.31K | $281.89K | New |
| Q3 2025 | 12.35K | $19.52K | Reduce |
| Q1 2026 | 98.91K | $69.24K | New |
| Q2 2026 | 1.01M | $1.25M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MXCT
- Vanguard Group 5.54M sh · $8.59M · Q4 2025
- Morgan Stanley 3.69M sh · $4.54M · Q2 2026
- BlackRock Inc 3.06M sh · $3.76M · Q2 2026
- Renaissance Technologies 1.91M sh · $2.35M · Q2 2026
- AQR Capital Management 1.88M sh · $2.32M · Q2 2026
- Two Sigma Investments 1.46M sh · $1.80M · Q2 2026
- Geode Capital Management 1.33M sh · $1.63M · Q2 2026
- Goldman Sachs Group 1.24M sh · $1.53M · Q2 2026
- Millennium Management 1.20M sh · $1.48M · Q2 2026
- Citadel Advisors 955.72K sh · $1.18M · Q2 2026
- Point72 Asset Management 299.85K sh · $368.82K · Q2 2026